| Moshe Bachar, MD | |
|
3180 N Point Pkwy, Ste 302, Alpharetta, GA 30005-4381 | |
| (404) 800-5181 | |
| (404) 800-5797 |
| Full Name | Moshe Bachar |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 3180 N Point Pkwy, Alpharetta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669736559 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 73154 (Georgia) | Secondary |
| 208M00000X | Hospitalist | 73154 (Georgia) | Secondary |
| 207R00000X | Internal Medicine | 73154 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Newnan Hospital, Inc | Newnan, GA | Hospital |
| Northside Hospital Forsyth | Cumming, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mind And Body Wellness Center Inc. | 5698185809 | 2 |
| North Atlanta Professional Services Llc | 0840291944 | 296 |
| Piedmont Hospitalist Physicians Llc | 1951299163 | 303 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
| Entity Name | Piedmont Hospitalist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548219660 PECOS PAC ID: 1951299163 Enrollment ID: O20040309000820 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
| Entity Name | Jewish Family & Career Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134287501 PECOS PAC ID: 9234127242 Enrollment ID: O20040506000024 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
| Entity Name | Emory Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
| Entity Name | Mind And Body Wellness Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053919225 PECOS PAC ID: 5698185809 Enrollment ID: O20201029000484 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
| Entity Name | Northview Wellness Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912623687 PECOS PAC ID: 6800267691 Enrollment ID: O20230112002671 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
| Entity Name | Global Medical Services Of Ga Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821785726 PECOS PAC ID: 1850756255 Enrollment ID: O20230614000433 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Moshe Bachar, MD 3180 N Point Pkwy, Ste 302, Alpharetta, GA 30005-4381 Ph: (404) 800-5181 | Moshe Bachar, MD 3180 N Point Pkwy, Ste 302, Alpharetta, GA 30005-4381 Ph: (404) 800-5181 |
News Archive
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue of the journal Neurology.
Dental x-rays could be a thing of the past thanks to a new knowledge transfer partnership between the University of Abertay Dundee and pioneering research firm IDMoS.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.
› Verified 4 days ago
Jeffrey Obiora, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy Ste 303, Alpharetta, GA 30005 Phone: 678-205-9004 | |
Dr. Jay Arthur Cherner, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 3330 Preston Ridge Rd, Suite 220, Alpharetta, GA 30005 Phone: 770-410-1600 Fax: 770-410-0006 | |
Randy Turkel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11600 Atlantis Place, Suite B, Alpharetta, GA 30022 Phone: 770-664-4449 Fax: 770-777-6496 | |
Xiaowen Wu, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 10800 Jones Bridge Rd, Ste A, Alpharetta, GA 30022 Phone: 678-867-0135 Fax: 678-867-0137 | |
Dr. Justin Chen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2575 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 800-930-0748 | |
Irfan Ali Syed, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3584 Old Milton Pkwy, Alpharetta, GA 30005 Phone: 678-691-3388 Fax: 678-395-7702 | |
Arezou Fatemi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy, Ste 303, Alpharetta, GA 30005 Phone: 678-205-9004 Fax: 678-205-9005 |